+1 (704) 266-3234

Antacids Global Market Report 2020 Including: 1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents 2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others 3) By Formulation Type: Tablet, Liquid, Powder, Others Covering: GlaxoSmithKline Plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC

Published on: Aug 2019 | From USD $4000 | Published By: THE BUSINESS RESEARCH COMPANY | Number Of Pages: 200

The antacids market consists of sales of antacids which are used to neutralize stomach acid, and treat acid reflux, heartburn and indigestion. It includes drug class such as proton pump inhibitors, H2 antagonist, surgical simulators and acid neutralizers in the form of either tablet, liquid or powder. Examples of antacids include Alka Seltzer, Maalox, Mylanta, Rolaids, Tums and Pepto-Bismol.

The global antacids market was valued at about $4.62 billion in 2018 and is expected to decline to $4.55 billion at a CAGR of -0.4% through 2022.

North America was the largest region in the antacids market in 2018. Asia Pacific and Latin America respectively.

Poor lifestyle choices resulting in higher prevalence of acidity is an important driver for the growth of the antacids market. Poor lifestyle choices involve deskbound jobs, poor quality of sleep and irregular dietary habits, which result in an increase in acidity level of the stomach and lead to gastroesophageal reflux disease. According to the American College of Gastroenterology, around 60 million Americans suffers from gastroesophageal reflux disease. This drives the demand for antacids.

The side effects related to antacids is a major restraint for the antacids market. Some of the common side effects of antacids include dose-dependent rebound hyperacidity and milk-alkali syndrome. Antacids containing aluminum hydroxide may also cause side effects such as constipation, aluminum-intoxication, osteomalacia, and hypophosphatemia. In addition, antacids when consumed with other acidic drugs might lead to absorption of both the drugs resulting in reduced efficiency of both the drugs.

Mouth-melting antacid is an emerging trend in the antacid market. Antacids were available in tablet, liquid and powder form until now, however, researchers have now come up with mouth-melting antacids which are made up of micro mouth melting granules that easily melt in the mouth. These granules present in the antacids act in the form of effervescent. An example of a mouth melting instant relief antacid is Sunpharma's 'Pepmelt', which integrates the effects of herbal constituents present in it with the contemporary mouth melting technology.

The manufacturers of antacids in the USA need to comply with CFR - Code of Federal Regulations Title 21 laid down by the FDA. According to these regulations, an over-the-counter (OTC) antacid product in a form suitable for oral administration is recognized safe and effective only if it meets the conditions related to active ingredients established by the regulatory body.

In March 2018, GlaxoSmithKline (GSK) acquired Novartis for $13 billion. This acquisition would help GSK's shareholder to seize the full worth of Novartis' consumer healthcare business. Also, it would help GSK expand its pharmaceutical portfolio. Novartis is a pharmaceutical firm manufacturing innovative drugs. It was founded in 1996 and is headquartered in Basel, Switzerland.

Major players in the market are GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd and AstraZeneca PLC.

Antacids Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antacids market.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the antacids? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antacids Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
• The Market Characteristics section of the report defines and explains the market.
• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market Segmentations break down market into sub markets.
• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents 2) Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others 3) By Formulation Type: Tablet, Liquid, Powder, Others

Companies Mentioned: GlaxoSmithKline plc, Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd, AstraZeneca PLC

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Antacids Market Characteristics
3. Antacids Market Size And Growth
3.1. Global Antacids Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Antacids Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Antacids Market Segmentation
4.1. Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Proton Pump Inhibitors
H2 Antagonist
Acid Neutralizers
Pro-Motility Agents
4.2. Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Others
4.3. Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Tablet
Liquid
Powder
Others
5. Antacids Market Regional And Country Analysis
5.1. Global Antacids Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Antacids Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6. Asia-Pacific Antacids Market
6.1. Asia-Pacific Antacids Market Overview
6.2. Asia-Pacific Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
7. China Antacids Market
7.1. China Antacids Market Overview
7.2. China Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
8. India Antacids Market
8.1. India Antacids Market Overview
8.2. India Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9. Japan Antacids Market
9.1. Japan Antacids Market Overview
9.2. Japan Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10. Australia Antacids Market
10.1. Australia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11. Indonesia Antacids Market
11.1. Indonesia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12. South Korea Antacids Market
12.1. South Korea Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13. Western Europe Antacids Market
13.1. Western Europe Antacids Market Overview
13.2. Western Europe Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14. UK Antacids Market
14.1. UK Antacids Market Overview
14.2. UK Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15. Germany Antacids Market
15.1. Germany Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16. France Antacids Market
16.4. France Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17. Eastern Europe Antacids Market
17.1. Eastern Europe Antacids Market Overview
17.2. Eastern Europe Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18. Russia Antacids Market
18.1. Russia Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19. North America Antacids Market
19.1. North America Antacids Market Overview
19.2. North America Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20. USA Antacids Market
20.1. USA Antacids Market Overview
20.2. USA Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21. South America Antacids Market
21.1. South America Antacids Market Overview
21.2. South America Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22. Brazil Antacids Market
22.1. Brazil Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23. Middle East Antacids Market
23.1. Middle East Antacids Market Overview
23.2. Middle East Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24. Africa Antacids Market
24.1. Africa Antacids Market Overview
24.2. Africa Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
25. Antacids Market Competitive Landscape And Company Profiles
25.1. Antacids Market Competitive Landscape
25.2. Antacids Market Company Profiles
25.2.1. GlaxoSmithKline plc
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Pfizer Inc
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Bayer AG
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Dr. Reddy's Laboratories Ltd
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. AstraZeneca PLC
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance
26. Key Mergers And Acquisitions In The Antacids Market
27. Antacids Market Trends And Strategies
28. Product Pipeline Analysis
29. Antacids Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. The Business Research Company
30.5. Copyright And Disclaimer

Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Table 3: Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 4: Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 5: Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 6: Global Antacids Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 7: Global Antacids Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 8: Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 9: Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 10: China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 11: China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 12: India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 13: India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 14: Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 15: Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 16: Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 17: Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 18: Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 19: Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 20: South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 21: South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 22: Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 23: Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 24: UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 25: UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 26: Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 27: Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 28: France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 29: France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 30: Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 31: Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 32: Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 33: Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 34: North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 35: North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 36: USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 37: USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 38: South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 39: South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 40: Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 41: Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 42: Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 43: Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 44: Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 45: Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Table 46: GlaxoSmithKline plc Financial Performance
Table 47: Pfizer Inc Financial Performance
Table 48: Bayer AG Financial Performance
Table 49: Dr. Reddy's Laboratories Ltd Financial Performance
Table 50: AstraZeneca PLC Financial Performance


Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
Figure 3: Global Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 4: Global Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 5: Global Antacids Market, Segmentation By Formulation Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 6: Global Antacids Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 7: Global Antacids Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 8: Asia-Pacific, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 9: Asia-Pacific, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 10: China, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 11: China, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 12: India, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 13: India, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 14: Japan, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 15: Japan, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 16: Australia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 17: Australia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 18: Indonesia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 19: Indonesia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 20: South Korea, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 21: South Korea, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 22: Western Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 23: Western Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 24: UK, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 25: UK, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 26: Germany, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 27: Germany, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 28: France, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 29: France, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 30: Eastern Europe, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 31: Eastern Europe, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 32: Russia, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 33: Russia, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 34: North America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 35: North America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 36: USA, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 37: USA, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 38: South America, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 39: South America, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 40: Brazil, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 41: Brazil, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 42: Middle East, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 43: Middle East, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 44: Africa, Antacids Market, Segmentation Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 45: Africa, Antacids Market, Segmentation Distribution Channel, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Figure 46: GlaxoSmithKline plc Financial Performance
Figure 47: Pfizer Inc Financial Performance
Figure 48: Bayer AG Financial Performance
Figure 49: Dr. Reddy's Laboratories Ltd Financial Performance
Figure 50: AstraZeneca PLC Financial Performance

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4000
USD $6000
USD $8000
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.